Clinical Trials Directory

Trials / Unknown

UnknownNCT04664283

Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography

Drug-coated Balloon Versus Drug-eluting Stent for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence Tomography:a Prospective Multi-center Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
254 (estimated)
Sponsor
Liu Bin · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

OCT allows precise evaluation of intimal injury after lesion preparation and may improve the acute results and long-term outcomes after paclitaxel drug-coated balloon angioplasty. This prospective multicenter randomized controlled study aims to evaluate the long-term efficacy and safety of paclitaxel coated balloon in the treatment of native large coronary arteries by OCT guided is not inferior to drug-eluting stent.

Conditions

Interventions

TypeNameDescription
DEVICEDCB for de Novo Lesions in Large Coronary Arteries Guided by Optical Coherence TomographyDCB for de Novo Lesions in Large Coronary Arteries Guided by both angiogram and Optical Coherence Tomography

Timeline

Start date
2021-01-01
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2020-12-11
Last updated
2020-12-11

Locations

2 sites across 1 country: China

Source: ClinicalTrials.gov record NCT04664283. Inclusion in this directory is not an endorsement.